Thanks to AIRC funding we have the opportunity to implement our research in the cancer field and to recruit two researchers in our group

We have recently received wonderful news: one of the funding requests has gone through! Indeed, an AIRC grant will allow us to implement our research on cancer, in parallel to ongoing studies in the field of cardiac regeneration and cardiotoxicity of anticancer therapies.

In fact, our laboratory aims at understanding the molecular mechanisms underlying cell differentiation and proliferation to develop new strategies to “block” cancer cells and to “unlock” the cardiac regenerative potential. In particular, with this project, we aim at studying the deregulations responsible for the development and progression of basal-like breast cancer, an aggressive tumor subtype.

In this research project, we will analyze the role and the molecular mechanisms activated by growth factors in cell differentiation. We hypothesize that pushing basal breast cancer cells towards a more differentiated phenotype would reduce their aggressiveness. The project has the potential to develop new differentiation strategies to prevent primary tumor cells from disseminating throughout the body and creating the so-called metastases, one of the major problems in solid tumor progression.

This funding will give us the opportunity to recruit two researchers (postgraduate or postdoc) in our research group in Bologna, from February / March 2021 for a total of five-year. Pre-doctoral researchers may also have the opportunity to start a PhD track. Interested and motivated researchers can contact us by email (duva.gabriele@gmail.com), attaching their CV.

Our researcher Dr. Nicola Pianca is the winner of the International Society for Heart Reseach Fellowship 2019!

Congratulations to Nicola Pianca, a postdoc researcher of our team, winner of the annual fellowship offered by SERVIER in collaboration with the European Section of the International Society for Heart Reseach (ISHR)

Dr. Pianca’s project focuses on the interaction between growth factors and hormones in the context of heart regeneration. Preliminary data are very promising and have already been presented at various international conferences over the last year, arousing some interest in the international scientific community.

In June 2019, we will present the project at the World Congress of the International Society for Heart Research (ISHR).

D’Uva lab receives Cariplo grant award on cancer and cardiotoxicity

We have just received very good news: we won the research grant “Cariplo – Young Researchers“.
This grant will allow us, in parallel to ongoing studies in the field of cardiac regeneration following a heart attack, to expand our research on cancer and the emerging problem of cardiotoxicity of anticancer therapies.
Cardiotoxicity, i.e. toxic effects on heart function, is responsible for a poor quality of life and reduced survival of cancer patients, regardless of the oncologic prognosis. The aim of our research is to develop innovative strategies to limit these side effects while increasing the efficacy of anti-cancer therapies targeting HER2 (a well-known oncogene also known as ERBB2) in breast cancer patients.
The project is in collaboration with the University of Bologna and Biomedical Research Foundation / University of Turin.
These funds will also give us the opportunity to recruit another researcher into my team. Soon we will post the details.
Happy 2018 to everyone!

D’Uva lab receives ERA-CVD grant award on cardiovascular disease

We are very happy to receive a research grant  ERA-CVD Call 2016 for Transnational Research Projects on Cardiovascular Diseases” of European Union’s Horizon 2020 Framework Programme. This grant gives us the opportunity to establish our lab in Italy, in IRCCS MultiMedica (Milan)!

The project, in collaboration with Hubrecht Institute (Netherlands), Ulm University (Germany) and Weizmann Institute of Science (Israel), will investigate heart regeneration using a comparative approach between different species.

Ischemic heart disease, such as myocardial infarction, causes a massive loss of cardiomyocytes and leads to the formation of fibrotic scar tissue, resulting in impaired cardiac function and ultimately, heart failure. Recently, it has been demonstrated that myocardium is naturally regenerated in the human heart. However, the rate of replacement is too low to repair large areas of damaged myocardium. Stimulating the very low intrinsic proliferation rate of cardiomyocytes is a promising strategy for cardiac repair in patients with heart failure. To identify such repair signals, this project will use zebrafish, where cardiomyocyte regeneration occurs naturally, and mice, where it does not. Different possible reasons for the difference in the regenerative capacity of lower vertebrate versus mammals will be explored. The goal is to develop regenerative medicine strategies based on endogenous cardiomyocyte capacities.

The American Association for Biomedical Research cites us as as an example of successful biomedical research that justifies the essential need for animals in medical research

National Association for Biomedical Research (NABR): The Essential Need for Animals in Medical Research

“Rodent research is creating an exciting horizon for cardiovascular disease treatment. Recent research with rats and mice has alerted scientists to the possibility of using growth factors (ref.21) and stem cells (ref. 22) to regenerate cardiac tissue after a heart attack. […] Human medicine would not be where it is today without the incredible contributions of these small yet mighty animals. […]
Ref. 21: D’Uva G, Aharonov A, Lauriola M, et al. Nat Cell Biol. 2015;17(5):627-38
Ref. 22: Ellison GM, Vicinanza C, Smith AJ, et al. Cell. 2013;154(4):827-42″

Winner of the poster session at ISCS 2012!

We won the poster session at the conference ISCS “The 4th Young Investigators Stem Cell Meeting” organized by the Israeli Stem Cell Society (December 2, 2012. Tel Aviv, Israel).

Presented project: D’Uva G, Lauriola M, Rajchman D, Weisinger K, Yarden Y and Tzahor E. “Heart regeneration and tumorigenicity: oncogenic ERBB2 as a driving force”.